Literature DB >> 11907203

The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription.

Masanori Kameoka1, Max Morgan, Marc Binette, Rodney S Russell, Liwei Rong, Xiaofeng Guo, Andrew Mouland, Lawrence Kleiman, Chen Liang, Mark A Wainberg.   

Abstract

Human immunodeficiency virus type-1 Tat has been proposed to play a role in the regulation of reverse transcription. We previously demonstrated that wild-type Tat can augment viral infectivity by suppressing the reverse transcriptase (RT) reaction at late stages of the viral life cycle in order to prevent the premature synthesis of potentially deleterious viral DNA products. Here we have performed a detailed analysis of the cell-free reverse transcription reaction to elucidate the mechanism(s) whereby Tat can affect this process. Our results show that Tat can suppress nonspecific DNA elongation while moderately affecting the specific initiation stage of reverse transcription. In addition, Tat has an RNA-annealing activity and can promote the placement of tRNA onto viral RNA. This points to a functional homology between Tat and the viral nucleocapsid (NC) protein that is known to be directly involved in this process. Experiments using a series of mutant Tat proteins revealed that the cysteine-rich and core domains of Tat are responsible for suppression of DNA elongation, while each of the cysteine-rich, core, and basic domains, as well as a glutamine-rich region in the C-terminal domain, are important for the placement of tRNA onto the viral RNA genome. These results suggest that Tat can play at least two different roles in the RT reaction, i.e., suppression of DNA polymerization and placement of tRNA onto viral RNA. We believe that the first of these activities of Tat may contribute to the overall efficiency of reverse transcription of the viral genome during a new round of infection as well as to enhanced production of infectious viral particles. We hypothesize that the second activity, illustrating functional homology between Tat and NC, suggests a potential role for NC in the displacement of Tat during viral maturation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907203      PMCID: PMC136076          DOI: 10.1128/jvi.76.8.3637-3645.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The GAG-like protein of the yeast Ty1 retrotransposon contains a nucleic acid chaperone domain analogous to retroviral nucleocapsid proteins.

Authors:  G Cristofari; D Ficheux; J L Darlix
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

2.  Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1.

Authors:  A Khorchid; H Javanbakht; S Wise; R Halwani; M A Parniak; M A Wainberg; L Kleiman
Journal:  J Mol Biol       Date:  2000-05-26       Impact factor: 5.469

3.  The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.

Authors:  Y X Feng; S Campbell; D Harvin; B Ehresmann; C Ehresmann; A Rein
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1.

Authors:  C Gabus; E Derrington; P Leblanc; J Chnaiderman; D Dormont; W Swietnicki; M Morillas; W K Surewicz; D Marc; P Nandi; J L Darlix
Journal:  J Biol Chem       Date:  2001-02-27       Impact factor: 5.157

5.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

6.  Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.

Authors:  F Kashanchi; E T Agbottah; C A Pise-Masison; R Mahieux; J Duvall; A Kumar; J N Brady
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Tat protein from human immunodeficiency virus forms a metal-linked dimer.

Authors:  A D Frankel; D S Bredt; C O Pabo
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

8.  Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography.

Authors:  S F Le Grice; F Grüninger-Leitch
Journal:  Eur J Biochem       Date:  1990-01-26

9.  Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.

Authors:  M Kuppuswamy; T Subramanian; A Srinivasan; G Chinnadurai
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

10.  Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1.

Authors:  S Cen; A Khorchid; H Javanbakht; J Gabor; T Stello; K Shiba; K Musier-Forsyth; L Kleiman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

View more
  19 in total

1.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Comparative analysis of RNA/protein dynamics for the arginine-rich-binding motif and zinc-finger-binding motif proteins encoded by HIV-1.

Authors:  Hui Wang; Xiaojing Ma; Yu-Shan Yeh; Yongjin Zhu; Matthew D Daugherty; Alan D Frankel; Karin Musier-Forsyth; Paul F Barbara
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

3.  Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.

Authors:  Atze T Das; Bep Klaver; Alex Harwig; Monique Vink; Marcel Ooms; Mireille Centlivre; Ben Berkhout
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.

Authors:  Charles W Dobard; Marisa S Briones; Samson A Chow
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  The HIV-1 Tat protein has a versatile role in activating viral transcription.

Authors:  Atze T Das; Alex Harwig; Ben Berkhout
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

6.  A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.

Authors:  Min-Hsuan Lin; Ann Apolloni; Vincent Cutillas; Haran Sivakumaran; Sally Martin; Dongsheng Li; Ting Wei; Rui Wang; Hongping Jin; Kirsten Spann; David Harrich
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

Review 7.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

Review 8.  Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.

Authors:  R J Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 9.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

Review 10.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.